Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Cash Flow-to-Debt Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Cash Flow-to-Debt Ratio of 0.13x as of June 2023, meaning its operating cash flow of $118.87 Million could theoretically repay 0% of its total liabilities ($900.37 Million) in one year. See 900904 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Shenqi Pharmaceutical Investmen.
Annual Cash Flow-to-Debt Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
Year-by-year debt coverage analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B. Check earnings quality score of Shanghai Shenqi Pharmaceutical Investmen to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | $207.79 Million | $689.01 Million | ▲ +24.3% |
| 2023 | 0.24x | $215.59 Million | $888.77 Million | ▼ -22.9% |
| 2022 | 0.31x | $319.23 Million | $1.01 Billion | ▲ +29.2% |
| 2021 | 0.24x | $184.26 Million | $756.45 Million | ▲ +89.3% |
| 2020 | 0.13x | $99.10 Million | $770.28 Million | ▼ -10.3% |
| 2019 | 0.14x | $128.28 Million | $894.60 Million | ▼ -49.0% |
| 2018 | 0.28x | $148.53 Million | $527.74 Million | ▲ +137.5% |
| 2017 | 0.12x | $66.99 Million | $565.34 Million | ▲ +11690.0% |
| 2016 | 0.00x | $570.41K | $567.56 Million | ▼ -98.7% |
| 2015 | 0.08x | $30.12 Million | $384.98 Million | — |